Proteasome Inhibitors in Cancer Therapy and their Relation to Redox Regulation

Author(s): Gulce Sari, Zehra Okat, Ali Sahin, Betul Karademir*.

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 44 , 2018

Become EABM
Become Reviewer

Abstract:

Redox homeostasis is important for the maintenance of cell survival. Under physiological conditions, redox system works in a balance and involves activation of many signaling molecules. Regulation of redox balance via signaling molecules is achieved by different pathways and proteasomal system is a key pathway in this process. Importance of proteasomal system on signaling pathways has been investigated for many years. In this direction, many proteasome targeting molecules have been developed. Some of them are already in the clinic for cancer treatment and some are still under investigation to highlight underlying mechanisms. Although there are many studies done, molecular mechanisms of proteasome inhibitors and related signaling pathways need more detailed explanations. This review aims to discuss redox status and proteasomal system related signaling pathways. In addition, cancer therapies targeting proteasomal system and their effects on redox-related pathways have been summarized.

Keywords: Proteasome inhibitors, redox status, signaling molecules, cancer therapy, redox homeostasis, proteasomal system.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 24
ISSUE: 44
Year: 2018
Page: [5252 - 5267]
Pages: 16
DOI: 10.2174/1381612825666190201120013
Price: $58

Article Metrics

PDF: 12
HTML: 2
EPUB: 1
PRC: 1